| 今开：0.0 | 昨收：0.378 |
| 最高：0.0 | 最低：0.0 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1418101.0 |
NeuBase Therapeutics(NBSE)05-14 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-060568 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-04 04:15
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-067779 Act: 34 Size: 943 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-14 18:05
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060759 Act: 34 Size: 18 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-04 04:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001104659-24-056957 Act: 34 Size: 206 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-16 22:15
$NeuBase Therapeutics(NBSE)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-24-000350 Act: 34 Size: 3 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-23 05:05
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 5.07 and 9.01 Accession Number: 0001104659-24-064320 Act: 34 Size: 211 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)05-06 19:35
$NeuBase Therapeutics(NBSE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-057213 Act: 34 Size: 19 KB 网页链接查看全文
NeuBase Therapeutics(NBSE)06-01 04:35
$NeuBase Therapeutics(NBSE)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001104659-24-067212 Act: 34 Size: 291 KB 网页链接查看全文
药时代2022-10-20 14:32
前言
心理学告诉人们，永远不要在晚上做决定，因为那是不理性的。
但我不听劝（决定玩会手机），打开手机，又一则关于裁员的新闻弹出，让我陷入了思考。
我焦虑了，也失眠了。
新闻的题目是：“NeuBase放弃了亨廷顿舞蹈症，消减60%的劳动力作为战略支点”
还贴心附了...查看全文
$NeuBase疗法(NBSE)$ 8-K/A [Amend] Current report, items 4.01 and 9.01 Accession Number: 0001104659-20-022491 Act: 34 Size: 25 KB 网页链接
$NeuBase疗法(NBSE)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001104659-20-022019 Act: 34 Size: 26 KB 网页链接
$NeuBase疗法(NBSE)$ 8-K Current report, items 4.01 and 4.02 Accession Number: 0001104659-20-020287 Act: 34 Size: 41 KB 网页链接
$NeuBase疗法(NBSE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001104659-20-003043 Act: 34 Size: 7 MB 网页链接
$NeuBase疗法(NBSE)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-20-002674 Act: 34 Size: 56 KB 网页链接
$NeuBase疗法(NBSE)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001104659-19-077303 Act: 34 Size: 25 KB 网页链接
$NeuBase疗法(NBSE)$ 8-K - Current report Filed: 2019-10-03 AccNo: 0001387131-19-007419 Size: 161 KBItem 4.01: Changes in Registrant's Certifying AccountantItem 9.01: Financial Statements and Exhibits 网页链接
$NeuBase疗法(NBSE)$ 424B3 - Prospectus [Rule 424(b)(3)] Filed: 2019-09-23 AccNo: 0001387131-19-007087 Size: 170 KB 网页链接
$NeuBase疗法(NBSE)$ 8-K - Current report Filed: 2019-09-23 AccNo: 0001387131-19-007089 Size: 215 KBItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal YearItem 9.01: Financial Statements and Exhibits 网页链接
$NeuBase疗法(NBSE)$ EFFECT - Notice of Effectiveness Filed: 2019-09-23 AccNo: 9999999995-19-002155 Size: 1 KB 网页链接